Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report

Abstract Background Remimazolam is a new ultra-short-acting benzodiazepine, and its sedative effect is prolonged in patients with hepatic impairment. This is the first report of remimazolam anesthesia in a patient with Child-Pugh C liver cirrhosis. Case presentation A 52-year-old female was diagnose...

Full description

Bibliographic Details
Main Authors: Satoshi Uchida, Daiki Takekawa, Eiji Hashiba, Reiko Kudo, Kazuyoshi Hirota
Format: Article
Language:English
Published: SpringerOpen 2022-12-01
Series:JA Clinical Reports
Subjects:
Online Access:https://doi.org/10.1186/s40981-022-00590-9
_version_ 1797973679239331840
author Satoshi Uchida
Daiki Takekawa
Eiji Hashiba
Reiko Kudo
Kazuyoshi Hirota
author_facet Satoshi Uchida
Daiki Takekawa
Eiji Hashiba
Reiko Kudo
Kazuyoshi Hirota
author_sort Satoshi Uchida
collection DOAJ
description Abstract Background Remimazolam is a new ultra-short-acting benzodiazepine, and its sedative effect is prolonged in patients with hepatic impairment. This is the first report of remimazolam anesthesia in a patient with Child-Pugh C liver cirrhosis. Case presentation A 52-year-old female was diagnosed with tongue cancer and scheduled for partial glossectomy. Preoperative examinations revealed Child-Pugh C liver cirrhosis, but the pathogenesis was unknown. We scheduled remimazolam anesthesia because it would stabilize her intraoperative circulation. We managed with a much lower-than-normal dose of remimazolam; even so, the patient required flumazenil to regain consciousness. She was admitted to the intensive care unit, but her consciousness remained clear even after the effect of flumazenil had worn off. Conclusion We experienced anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis. Even conservative use of remimazolam in patients with severe hepatic dysfunction may result in emergence times that are delayed longer than expected.
first_indexed 2024-04-11T04:08:08Z
format Article
id doaj.art-0c9231ee925644c3a8d83d56d490315b
institution Directory Open Access Journal
issn 2363-9024
language English
last_indexed 2024-04-11T04:08:08Z
publishDate 2022-12-01
publisher SpringerOpen
record_format Article
series JA Clinical Reports
spelling doaj.art-0c9231ee925644c3a8d83d56d490315b2023-01-01T12:14:49ZengSpringerOpenJA Clinical Reports2363-90242022-12-01811410.1186/s40981-022-00590-9Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case reportSatoshi Uchida0Daiki Takekawa1Eiji Hashiba2Reiko Kudo3Kazuyoshi Hirota4Department of Anesthesiology, Hirosaki University Graduate School of MedicineDepartment of Anesthesiology, Hirosaki University Graduate School of MedicineDivision of Intensive Care, Hirosaki University HospitalDepartment of Anesthesiology, Hirosaki University Graduate School of MedicineDepartment of Anesthesiology, Hirosaki University Graduate School of MedicineAbstract Background Remimazolam is a new ultra-short-acting benzodiazepine, and its sedative effect is prolonged in patients with hepatic impairment. This is the first report of remimazolam anesthesia in a patient with Child-Pugh C liver cirrhosis. Case presentation A 52-year-old female was diagnosed with tongue cancer and scheduled for partial glossectomy. Preoperative examinations revealed Child-Pugh C liver cirrhosis, but the pathogenesis was unknown. We scheduled remimazolam anesthesia because it would stabilize her intraoperative circulation. We managed with a much lower-than-normal dose of remimazolam; even so, the patient required flumazenil to regain consciousness. She was admitted to the intensive care unit, but her consciousness remained clear even after the effect of flumazenil had worn off. Conclusion We experienced anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis. Even conservative use of remimazolam in patients with severe hepatic dysfunction may result in emergence times that are delayed longer than expected.https://doi.org/10.1186/s40981-022-00590-9RemimazolamFlumazenilLiver cirrhosisChild-Pugh score
spellingShingle Satoshi Uchida
Daiki Takekawa
Eiji Hashiba
Reiko Kudo
Kazuyoshi Hirota
Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report
JA Clinical Reports
Remimazolam
Flumazenil
Liver cirrhosis
Child-Pugh score
title Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report
title_full Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report
title_fullStr Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report
title_full_unstemmed Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report
title_short Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report
title_sort anesthetic management with remimazolam in a patient with child pugh c liver cirrhosis a case report
topic Remimazolam
Flumazenil
Liver cirrhosis
Child-Pugh score
url https://doi.org/10.1186/s40981-022-00590-9
work_keys_str_mv AT satoshiuchida anestheticmanagementwithremimazolaminapatientwithchildpughclivercirrhosisacasereport
AT daikitakekawa anestheticmanagementwithremimazolaminapatientwithchildpughclivercirrhosisacasereport
AT eijihashiba anestheticmanagementwithremimazolaminapatientwithchildpughclivercirrhosisacasereport
AT reikokudo anestheticmanagementwithremimazolaminapatientwithchildpughclivercirrhosisacasereport
AT kazuyoshihirota anestheticmanagementwithremimazolaminapatientwithchildpughclivercirrhosisacasereport